IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 80 filers reported holding IGM BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,763 | +12.0% | 14,223 | +23.8% | 0.00% | – |
| Q2 2023 | $106,062 | +82.1% | 11,491 | +171.1% | 0.00% | – |
| Q1 2023 | $58,230 | -15.4% | 4,238 | +4.7% | 0.00% | – |
| Q4 2022 | $68,857 | -17.0% | 4,048 | +10.9% | 0.00% | – |
| Q3 2022 | $83,000 | +43.1% | 3,649 | +13.5% | 0.00% | – |
| Q2 2022 | $58,000 | -23.7% | 3,214 | +12.9% | 0.00% | – |
| Q1 2022 | $76,000 | -9.5% | 2,847 | 0.0% | 0.00% | – |
| Q4 2021 | $84,000 | -54.8% | 2,847 | 0.0% | 0.00% | – |
| Q3 2021 | $186,000 | +66.1% | 2,847 | +113.1% | 0.00% | – |
| Q2 2021 | $112,000 | +27.3% | 1,336 | +16.4% | 0.00% | – |
| Q1 2021 | $88,000 | -12.0% | 1,148 | +1.1% | 0.00% | – |
| Q4 2020 | $100,000 | +14.9% | 1,136 | -3.4% | 0.00% | – |
| Q3 2020 | $87,000 | -20.2% | 1,176 | -20.6% | 0.00% | – |
| Q2 2020 | $109,000 | +153.5% | 1,482 | +85.0% | 0.00% | – |
| Q1 2020 | $43,000 | +16.2% | 801 | -18.5% | 0.00% | – |
| Q4 2019 | $37,000 | – | 983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |